Whole-Brain Proton MR Spectroscopic Imaging in Parkinson's Disease

Journal of Neuroimaging

Volumn 24, Issue 1, 2014, Pages 39-44

  Levin, Bonnie E ^a,b   Katzen, Heather L ^a   Maudsley, Andrew ^a   Post, Judith ^a   Myerson, Connie ^b   Govind, Varan ^a   Nahab, Fatta ^a   Scanlon, Blake ^b   Mittel, Aaron ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

Author keywords

Cognition; MRS imaging; Parkinson's disease

Indexed keywords

CHOLINE; CREATININE; GLYCEROPHOSPHORYLCHOLINE; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; ASPARTIC ACID; BIOLOGICAL MARKER; CREATINE; N-ACETYLASPARTATE;

ADULT; ARTICLE; BRAIN; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GRAY MATTER; HUMAN; MALE; METABOLITE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PARKINSON DISEASE; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; WHITE MATTER; YOUNG ADULT; AGED; ANALOGS AND DERIVATIVES; METABOLISM; MIDDLE AGED; MOLECULAR IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

ADULT; AGED; ASPARTIC ACID; BIOMARKERS; BRAIN; CHOLINE; CREATINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR IMAGING; PARKINSON DISEASE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84892405210     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2012.00733.x     Document Type: Article

References (29)

1. Choe B-Y, Park J-W, Lee K-S, et al. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Invest Radiol 1998;33:450-455.
2. Holshauser BA, Komu M, Moller HE, et al. Localised proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Reson Med 1995;33:589-594
3. Taylor-Robinson SD, Turjanski N, Bhattacharya S, et al. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metab Brain Dis 1999;14:45-55.
4. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:239-242.
5. Ellis CM, Lemmens G, Williams SCR, et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa- treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology 1997;49:438-444.
6. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995;37:204-210.
7. Cruz CJ, Aminoff MJ, Meyerhoff DJ, et al. Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magn Reson Imag 1997;15:619-624.
8. Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997;120:1541-1552.
9. Clarke CE, Lowry M, Horsman A Unchanged basal ganglia N- acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Mov Disord 1997; 12:297-301
10. Lucetti C, del Dotto P, Gambaccini G, et al. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurol Sci 2001;22:69-70
11. Hu MTM, Taylor-Robinson SD, Chaudhuri KR, et al. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry 1999;67:20-26
12. Camicioli RM, Korzan JR, Foster SL, et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 2004; 354:177-180
13. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
14. Levin BE, Katzen HL. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. Adv Neurol 2005;96:84-94.
15. Maudsley AA, Darkazanli A, Alger JR, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006;19(4):492-503.
16. Maudsley AA, Domenig C, Govind V, et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magn Reson Med 2009;61(3):548-559
17. Smith SA, Levante TO, Meier BH, et al. Computer simulations in magnetic resonance. An object-oriented programming approach. J Mag Reson Ser A 1994;106:75-105
18. Govindaraju V, Young K, Maudsley AA, et al. Chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000;13(3):129-153.
19. Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, et al. Cortical dysfunction in non-demented parkinson's disease patients: a combined (31) P-MRS and (18)FDG-PET study. Brain 2000;123 (Pt 2):340-352.
20. Martin WR, Wieler M, Gee M, et al. Temporal lobe changes in early, untreated parkinson's disease. Mov Disord 2009;24(13):1949-1954.
21. Camicioli R, Moore MM, Kinney A, et al. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003;18(7):784-790.
22. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Longitudinal evaluation of cerebral morphological changes in parkinson's disease with and without dementia. J Neurol 2005;252(11):1345-1352.
23. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007;33(6)599-614
24. Reyngoudt H, Claeys T, Vlerick L, et al. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study. Eur J Radiol 2012;81(3):e223-e231 [Epub 2011 Feb 22].
25. Hattingen E, Magerkurth J, Pilatus U, et al. Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis. NMR Biomed 2011;24(5):536-546. doi: 10.1002/nbm.1621 [Epub 2010 Dec 12].
26. Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007;32(12):2490-2499 [Epub 2007 Apr 11].
27. Hannay HJ, Falgout JC, Leli DA, et al. Focal right temporo-occipital blood flow changes associated with judgment of line orientation. Neuropsychologia 1987;25(5):755-763.
28. Pereira JB, Junque C, Marti MJ, et al. Structural brain correlates of verbal fluency in parkinson's disease. Neuroreport 2009;20(8):741-744.
29. Tomaszewki Farias S, Harrington G, Broomand C, et al. Differences in functional MR imaging activation patterns associated with confrontation naming and responsive naming. AJNR Am J Neuroradiol 2005;26(10):2492-2499.